Clinical Trial Update: Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating morning vs evening dosing of valsartan and lisinopril in patients with diabetes and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension

Drugs mentioned

• DIOVAN (valsartan)
• Lisinopril (Lisinopril)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED